Methods and compositions for treating cancer using proteasome inhibitors
CA 2504933 C · Owner: Dana-Farber Cancer Institute, Inc. · Inventors: Mitsiades, Constantine S.; Anderson, Kenneth C.; Mitsiades, Nicholas
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to therapeutic compositions for treating cancer or preventing the growth of cancer cells e.g. tumor growth, in a subject. , The present invention also relates to methods for treating cancer e.g. inhibiting tumor growth, in a subject who has become resistant to treatment by administering to a subject an effective amount of a proteasome inhibitor and an effective amount of a therapeutic agent e.g. a chemotherapeutic , agent. The present invention further relates to methods for purging bone marrow, i.e. removing cancer cells from bone marrow by exposing the bone , marrow cells to a proteasome inhibitor and a therapeutic agent e.g. a , chemotherapeutic agent.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 6, 2003 and granted October 16, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 6, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 6, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.